Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features
To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...
Na minha lista:
| Publicado no: | J Clin Microbiol |
|---|---|
| Principais autores: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120267/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11880402/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.3.837-845.2002 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
